Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, 55902, United States.
Hum Pathol. 2024 May;147:114-128. doi: 10.1016/j.humpath.2024.01.014. Epub 2024 Feb 13.
The term "hemangioendothelioma" is used for endothelial neoplasms of intermediate malignancy and describes a group of rare neoplasms having biologic behavior falling in between that of the benign hemangiomas and fully malignant angiosarcomas. The hemangioendotheliomas fall into several specific, clinicopathologically and genetically distinct entities, specifically epithelioid hemangioendothelioma, kaposiform hemangioendothelioma, papillary intralymphatic angioendothelioma and retiform hemangioendothelioma (hobnailed hemangioendothelioma), pseudomyogenic hemangioendothelioma, composite hemangioendothelioma, and YAP1::TFE3-fused hemangioendothelioma. The clinical, morphologic, immunohistochemical, and genetic features, and the differential diagnosis of each of these rare entities are discussed in this review.
“血管内皮细胞瘤”一词用于描述中等恶性的内皮肿瘤,它描述了一组罕见的肿瘤,其生物学行为介于良性血管瘤和完全恶性的血管肉瘤之间。血管内皮细胞瘤分为几种特定的、临床病理和遗传上明显不同的实体,具体包括上皮样血管内皮细胞瘤、卡波西样血管内皮细胞瘤、乳头状淋巴管内血管内皮瘤和网状血管内皮细胞瘤(钉状血管内皮细胞瘤)、假肌源性血管内皮细胞瘤、复合性血管内皮细胞瘤和 YAP1::TFE3 融合的血管内皮细胞瘤。本文综述了这些罕见实体的临床、形态学、免疫组织化学和遗传学特征,以及每种实体的鉴别诊断。